President Donald Trump signed a $1.3 trillion spending measure Friday, averting a government shutdown at midnight, and renewing critical protections for medical marijuana patients and providers.
The bill’s passage will allow millions of medical cannabis patients and providers to breathe easier.
Yesterday the president said he was considering a veto, because the bill does not contain full funding for a border wall with Mexico and does not address some 800,000 “Dreamer” immigrants who are now protected from deportation under a program that he has moved to eliminate. He said he signed it in order to provide needed money for the military.
On Friday morning, Trump cast further doubt on whether he would back the massive spending bill. Then, adding to the drama, he scheduled a news conference. Telegraphing the outcome, an internal White House television feed advertised the event this way: “President Trump Participates in a Bill Signing.”
The bill’s passage and presidential signature will allow millions of medical cannabis patients and providers to breathe easier, knowing that the Rohrabacher-Blumenauer provision is in effect. That bipartisan provision, championed by Rep. Dana Rohrabacher (R-CA) and Rep. Earl Blumenauer (D-OR), ensures that federal funds cannot be used to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.” The provision covers the 30 states that have legalized the medical use of cannabis. The rule affects agencies that include the Drug Enforcement Administration and local federal prosecutors, which all operate under the DOJ.
Those budget provisions have been in effect since 2014. Because the provision is a budgetary amendment, and not a standalone law, it must be explicitly re-authorized by Congress as part of either a continuing resolution or a new fiscal year appropriations bill in order to maintain in effect.
Sessions Failed to Kill the Amendment
Last year, Attorney General Jeff Sessions wrote a letter to Congressional leaders asking them to remove the provision. “I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions,” he wrote, “particularly in the midst of a historic drug epidemic and potentially long-term uptick in violent crime.”
Consequently, Rep. Pete Sessions (R-TX, no relation) prevented the Rohrabacher-Blumenauer provision from moving forward out of the House Rules Committee, which Sessions chairs. Fortunately for MMJ patients, Sen. Patrick Leahy (D-VT) introduced the same provision into the Senate version of the spending bill, and the language survived the long negotiations to arrive at a compromise bill.
A Popular Compromise
The House easily approved the spending package Thursday, 256-167, a bipartisan tally that underscored the popularity of the compromise, which funds the government through September. It beefs up military and domestic programs, delivering federal funds to every corner of the country.
This was the fifth, and last, stopgap spending measure passed by Congress this fiscal year.